Clinical trial
The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
NCT02798172 is registered in ClinicalTrials.gov with Fourth People's Hospital of Shenyang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
- Lead sponsor
- Fourth People's Hospital of Shenyang
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- August 31, 2015
- Enrollment
- 81 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.